Congress — Biosimilar News

Wednesday, August 10th

About Us
Copyright
Disclaimer
Privacy Policy
Terms&Conditions
Contact Us
- Advertisement
Site Map

News/Headlines
Events
- Upcoming Events
- Past Events
Guidelines
Policies
Research/Analysis

USEFUL TIP: In order not to miss any updates, follow us on Twitter or sign up for our Newsletter..

Follow Us

Subscribe by RSS
Contact us via E-Mail
Follow us on Twitter
Follow us on LinkedIn

Sign up for our newsletter

Email Address :

All-time Popular Posts

A biobetter trastuzumab is on the way
EGA president calls on Member States to boost market access for biosimilars in the EU
3rd Forum on Biosimilars
Pfizer starts biosimilar rituximab Phase I/II trial
Indian Biosimilars Market
World’s first biosimilar antibody* is approved in Korea
A biosimilar manufacturer: Celltrion
GPhA applauds Senate HELP Committee for favorably reporting user fee proposals

Tags

adalimumab Amgen Celltrion Conference EMA Enbrel Etanercept EU Europe FDA Guideline Herceptin Hospira Humira India infliximab Interchangeability London Mabthera Monoclonal Antibodies Phase III Press Release Remicade Remsima Rituxan rituximab Roche Sandoz South Korea trastuzumab UK USA

Archives

Archives

Twitter Updates

Post Tagged with: "Congress"

© Copyright 2016 — Biosimilar News. All Rights Reserved Powered by

Wordpress